side effects of bpc 157 oral BPC-157 (Oral) (Oral BPC-157) — Dosing, Effects, FDA Status & Research | PeptIQ Multifunctionality and Possible Medical Application

"Methylation of nicotinamide with soluble enzyme system from rat liver (in Eng)

The 6/3/3mg ratio refers to the amount of each peptide included in the blend

No delayed-onset adverse effects emerged that were not apparent in the initial weeks of treatment

BPC 157 was given per-orally, in drinking water (10 g/kg or 10 ng/kg, 0.16 g/ml, or 0.16 ng/ml 12 ml/rat/day) till sacrifice, or alternatively, 10 g/kg and 10 ng/kg intraperitoneally once daily

it is not available through the NHS or any regulated UK pharmacy and remains in clinical development

Some users report improved energy and slightly enhanced recovery from workouts